2025-12-28 - Analysis Report
Here's a breakdown of Intuitive Surgical (ISRG) based on the provided data, combining numerical reporting with simple analysis:

**0) Numerical Summary:**

*   **ISRG Cumulative Return:** 113.53%
*   **VOO (S&P 500) Cumulative Return:** 103.21%
*   **Divergence (ISRG vs VOO):**
    *   Current: 10.7
    *   Relative Divergence: 35.5
*   **Current Price:** $577.81
*   **Moving Averages:**
    *   5-day SMA: $576.92
    *   20-day SMA: $565.53
    *   60-day SMA: $531.81
*   **Market Risk Indicator (MRI):** 1.0 (High Investment Recommended)
*   **RSI:** 51.47
*   **PPO:** 0.0937
*   **Recent Relative Divergence Change (20 days):** +8.0 (Positive increase)
*   **Expected Return:** 23.9%
*   **Analyst Consensus:** Buy (Mean: 2.06)
*   **Target Price (avg/high/low):** $599.60 / $700.00 / $378.00

**1) Return Rate Comparison (ISRG vs. VOO):**

*   **Company Overview:** Intuitive Surgical Inc. designs, manufactures, and markets robotic surgical systems.
*   **Return Rate Analysis:** ISRG has outperformed the S&P 500 (VOO) with a cumulative return of 113.53% compared to VOO's 103.21%. The current divergence is 10.7 percentage points, which puts the relative divergence at 35.5 (meaning it is roughly mid range based on recent fluctuations).

    **Alpha, Beta Analysis:**

    *   **CAGR:** Ranges significantly, showing periods of high growth (e.g., 68% in 2015-2017) and decline (e.g., -23% in 2020-2022). The last period shown (2023-2025) had the highest growth at 76%.
    *   **MDD:** The Maximum Drawdown is consistently high, indicating significant risk/volatility.
    *   **Alpha:** Indicates ISRG's performance relative to its benchmark. Positive alpha (e.g., 49% in 2016-2018) means it outperformed, while negative alpha (e.g., -29% in 2018-2020) indicates underperformance. Alpha values seem to lag behind CAGR, with positive Alphas showing during periods when CAGRs were previously high.
    *   **Beta:** Beta is generally low, and has been increasing, suggesting that ISRG has become increasingly correlated with the overall market in recent years.
    *   **Cap:** Market Capitalization, has generally increased over the period.

**2) Recent Stock Price Fluctuations:**

*   The current price of ISRG is slightly above both its 5-day and 20-day Simple Moving Averages (SMAs), suggesting a potential short-term upward trend. The price is also significantly above the 60-day SMA, indicating a strong medium-term trend. The marginal change in price suggests relatively stable price movement at the current time.

**3) RSI, PPO, and Divergence Analysis:**

*   **MRI:** A high MRI of 1.0 suggests a strong investment recommendation based on market risk.
*   **RSI:** An RSI of 51.47 is considered neutral, not indicating overbought or oversold conditions.
*   **PPO:** A PPO of 0.0937 suggests that the short-term moving average is slightly above the long-term moving average, indicating a slight upward trend in momentum.
*   **Hybrid Signal:** The "cash_0%_Buy 90% of cash" signal suggests a strong buy recommendation, allocating most available capital to ISRG, in line with the high MRI.
*   **Recent Relative Divergence Change:** The increase of 8.0 suggests recent outperformance relative to the comparison benchmark.
*   **Expected Return:** A projected 23.9% expected return is very attractive, indicating significant potential for long-term investors.

**4) Recent News & Significant Events:**

*   **Positive News:**
    *   "Intuitive Surgical Stock Surged 30%, Here's Why" indicates significant positive momentum.
    *   "Intuitive Surgical (ISRG): Revisiting Valuation After a 25% Three-Month Share Price Surge" further reinforces positive price action.
    *   "Is ISRG's 20% Procedure Growth the New Normal or a Peak?" focuses on fundamental drivers of growth.
    *   "What Are the Best Healthcare Stocks to Buy Now?" suggests positive analyst outlook compared to peers.
*   **Neutral/Mixed News:**
    *   "Intuitive Surgical (ISRG) Stock: What to Know Before the Market Opens on Dec. 26, 2025" seems to provide a general overview of the stock.
*   **Potentially Negative News:**
    *   "Intuitive Surgical, Inc. $ISRG Shares Sold by Beacon Investment Advisory Services Inc." indicates institutional selling pressure, although the impact may be limited.

**4-2) Analyst Opinions:**

*   The consensus rating of "Buy" with a mean of 2.06 indicates a generally positive outlook from analysts. The average target price of $599.60 is above the current price, suggesting further upside potential.

**5) Recent Earnings Analysis:**

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-10-22 | 1.98 | 2.51 B$   |
| 2025-07-23 | 1.84 | 2.44 B$   |
| 2025-04-23 | 1.95 | 2.25 B$   |
| 2024-10-18 | 1.59 | 2.04 B$   |
| 2025-10-22 | 1.59 | 2.04 B$   |

*   **Analysis:** ISRG has shown consistent revenue and EPS growth over the past several quarters. Both EPS and Revenue generally increasing period on period. This consistent revenue and earnings growth signals a strong fundamental business.

**6) Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-09-30   | $2.51B   | 66.36%        |
| 2025-06-30   | $2.44B   | 66.31%        |
| 2025-03-31   | $2.25B   | 64.69%        |
| 2024-12-31   | $2.41B   | 68.04%        |
| 2024-09-30   | $2.04B   | 67.41%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE    |
|--------------|-----------|--------|
| 2025-09-30   | $16.93B   | 4.16%  |
| 2025-06-30   | $17.85B   | 3.69%  |
| 2025-03-31   | $17.11B   | 4.08%  |
| 2024-12-31   | $16.43B   | 4.17%  |
| 2024-09-30   | $15.58B   | 3.63%  |

*   **Analysis:** Revenue has been steadily increasing, demonstrating solid growth. High profit margins (above 64%) indicate efficient operations and pricing power. Equity has generally increased, and ROE has fluctuated, suggesting that the company is generally profitable and is generating returns on shareholders' equity.

**7) Comprehensive Analysis:**

*   **Overall:** ISRG appears to be a strong investment candidate based on the data. It has outperformed the S&P 500, shows consistent revenue and earnings growth, and has positive analyst sentiment.
*   **Positives:** Strong growth momentum, high profit margins, positive analyst ratings, and a high MRI.
*   **Negatives:** The high MDD indicates potential volatility. Some institutional selling pressure was indicated, although this could be noise in the data.
*   **Recommendation:** The "Buy" signal is supported by the data, with a positive outlook for long-term investors. The news articles highlighting recent surges and growth prospects further reinforce this recommendation.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.